| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |